Format

Send to

Choose Destination
Oncotarget. 2015 May 10;6(13):11664-75.

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.

Author information

1
Aix-Marseille Univ, CRO2, UMR 911, Marseille 13284, France.
2
APHM, Timone Hospital, Department of Neuro-Oncology, Marseille 13005, France.
3
APHM, Timone Hospital, Department of Neuro-Surgery, Marseille 13005, France.
4
APHM, North Hospital, Transfer Laboratory, Marseille 13015, France.
5
APHM, Timone Hospital, Department of Radiotherapy, Marseille 13005, France.
6
APHM, Timone Hospital, Department of Anatomopathology, Marseille 13005, France.

Abstract

Angiogenesis is one of the key features of glioblastoma (GBM). Our objective was to explore the potential changes of angiogenic factors in GBM between initial diagnosis and recurrence after radiotherapy-temozolomide (RT/TMZ). Paired frozen tumors from both initial and recurrent surgery were available for 29 patients. Screening of genes expressions related to angiogenesis was performed using RT- PCR arrays on 10 first patients. Next, RNA expressions of the selected genes were analyzed on all samples. Protein expression was examined by immunohistochemistry. The anti-tumor effect of AMD3100 (anti-CXCR4) was tested in GBM explants. In the screening step, the initial-recurrence expression changes contributed to a selection of seven genes (VEGFA, VEGFR2, VEGFR1, CXCL12, CXCR4, uPA HIF1α). By quantitative RT-PCR, RNA expressions of CXCR4 (p = 0.029) and CXCL12 (p = 0.107) were increased while expressions of HIF1α (p = 0.009) and VEGFR2 (p = 0.081) were decreased at recurrence. Similarly, CXCL12 protein expression tended to increase (p = 0.096) while VEGFR2 staining was decreased (p = 0.004) at recurrence. An increase of anti-tumoral effect was observed with the combination of AMD3100 and RT/TMZ versus RT/TMZ alone in GB explants. Recurrence of GB after chemo-radiation could be associated with a switch of angiogenic pattern from VEGFR2-HIF1α to CXCL12-CXCR4 pathway, leading to new perspectives in angiogenic treatment.

KEYWORDS:

angiogenesis; glioblastoma; paired; switch

PMID:
25860928
PMCID:
PMC4484484
DOI:
10.18632/oncotarget.3256
[Indexed for MEDLINE]
Free PMC Article

Publication type, MeSH terms, Substances

Publication type

MeSH terms

Substances

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center